Biogen Idec Inc. (BIIB)
Loading...
Symbols:
BIIB Forum Topics
- All Comments on BIIB
- General Discussion on BIIB
- Unintended Consequences - Fast Money Recap (10/6/08) [view article]
- Hide in the Fetal Position - Fast Money Recap (10/2/08) [view article]
- Cancer Stocks Plunge Following ASCO Meeting [view article]
- Three Biotech ETFs: A Way To Follow the 'Smart Money' into Healthcare [view article]
- Biogen-Idec, Elan: Panic Selling Creates Interesting Opportunity [view article]
- Cancer Stocks on the Go: Winners and Losers [view article]
- Icahn Favorites Have Abysmal Month [view article]
- What Are Your Biogen Idec Options? [view article]
- Infamous Anniversary - Cramer's Stop Trading! (8/1/08) [view article]
- Friday Options Update: ELN, BIIB, ANR, ORCL, MAR, A, IP, HBC, RKH [view article]
- Time for Biotech? - Fast Money Recap (07/29/08) [view article]
- Cancer Stocks: Lagging Again [view article]
Recent BIIB Articles
- Four Thoughts on the Imclone/Lilly Deal
- Unintended Consequences - Fast Money Recap (10/6/08)
- FDA Publishes List of Potential Drug Risks
- Hide in the Fetal Position - Fast Money Recap (10/2/08)
- End The Misery - Fast Money Recap (9/11/08)
- Drug Safety Updates For Elan, Biogen, Amylin, and Lilly
- Three Biotech ETFs: A Way To Follow the 'Smart Money' into Healthcare
- Icahn Boosts Stake in Biogen Idec to 6% Following TYSABRI Sell-Off
- Biogen-Idec, Elan: Panic Selling Creates Interesting Opportunity
- Icahn Favorites Have Abysmal Month
- Full List of Articles »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
loading ...
s
Cancer Stocks Plunge Following ASCO Meeting [view article]
Dear Sir,What is your current opinion on Insmed?
Thank you very much,
Miles Roberts Reply
Cancer Stocks Soar With Annual ASCO Meeting [view article]
Your table is too over-crowded to be useful. Next time skip the industry, HQ city and state as it is meaningless except for job seekers. Nice try though. ReplyBrochstein
Cancer Stocks on the Go: Winners and Losers [view article]
You get what you pay for, then. If I could publish this list in advance, well, I would be doing it from my boat in the Bahamas!Many investors look at price action in order to alert them to areas where they should be focused. Is the move overdone (take profits), or is it sustainable (consider buying). Reply
Cancer Stocks on the Go: Winners and Losers [view article]
Telling me about stocks after the fact don't do shit for me!!! ReplySearching for Value Investments in the Drug Stock Universe [view article]
I owned Pfizer for a long time and gave up in disgust. It does have a nice yield but zero growth instock price over two years since I sold it and dropped severely before that. ReplyCalderone
Top Picks for 2007 from JPMorgan HealthCare Analysts [view article]
Sorry, but huge cramer fan. He liked GILD and TMO before they presented. Also, 4 small cap drug stocks are heading toward fda approval and will likely double this year, or early next year. SVNT, IDEV, SNUS, and BMRN. Biotech is one field that is not usually moving together as a unit. It is pipeline driven. These will double for no other reason than they are nearing their fda approval. I follow Cramer pretty closely, cramersez.com or thestreet.com are good sites to keep tabs on his picks. ReplyHematology Meeting to Boost Amgen, Biogen Idec and Other Biotechs [view article]
anyone here follow imgn or alth.. imgn should report data for MM with drug n901-dm1. ReplyEditors
Earnings Schedule and Estimates for Wednesday, Feb. 15 [view article]
Sanz,Please look at our daily post identifying which transcripts will be posted: seekingalpha.com/artic...
We're looking to expand our coverage of transcripts. The fastest way for a new company to get covered is for investors to contact them and ask them to email us to request coverage.
Thanks!
SA Editors Reply
visu
Earnings Schedule and Estimates for Wednesday, Feb. 15 [view article]
hi,I have been reading seeking alpha transcripts for more than two quarters now, you speed is fantastic. But, one thing i have noticed you cover all the industry toppers. I would like to know if you are covering these tickers: RUTH, PBH, STKL, and CALL? All four companies have their earnings release this week.
Also, I don't know if you are covering any ticker, until the trans appears. Of course previous transcripts gives us an indication. But, is there a way to know your coverge in advance?
Thanks.
You are doing a great job. Keep it up.
Sanz Reply